JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204170200 on June 26, 2002

J. Biol. Chem., Vol. 277, Issue 37, 33670-33675, September 13, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/37/33670    most recent
M204170200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Hatefi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Hatefi, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Proton Channel of the Energy-transducing Nicotinamide Nucleotide Transhydrogenase of Escherichia coli*

Mutsuo YamaguchiDagger , C. David Stout§, and Youssef HatefiDagger

From the Departments of Dagger  Molecular and Experimental Medicine and § Molecular Biology, The Scripps Research Institute, La Jolla, California 92037

Received for publication, April 29, 2002, and in revised form, June 26, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The nicotinamide nucleotide transhydrogenases of mitochondria and bacteria are proton pumps that couple direct hydride ion transfer between NAD(H) and NADP(H) bound, respectively, to extramembranous domains I and III to proton translocation by the membrane-intercalated domain II. To delineate the proton channel of the enzyme, 25 conserved and semiconserved prototropic amino acid residues of domain II of the Escherichia coli transhydrogenase were mutated, and the mutant enzymes were assayed for transhydrogenation from NADPH to an NAD analogue and for the coupled outward proton translocation. The results confirmed the previous findings of others and ourselves on the essential roles of three amino acid residues and identified another essential residue. Three of these amino acids, His-91, Ser-139, and Asn-222, occur in three separate membrane-spanning alpha  helices of domain II of the beta  subunit of the enzyme. Another residue, Asp-213, is probably located in a cytosolic-side loop that connects to the alpha  helix bearing Asn-222. It is proposed that the three helices bearing His-91, Ser-139, and Asn-222 come together, possibly with another highly conserved alpha  helix to form a four-helix bundle proton channel and that Asp-213 serves to conduct protons between the channel and domain III where NADPH binding energy is used via protein conformation change to initiate outward proton translocation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nicotinamide nucleotide transhydrogenases (TH)1 of mitochondria and microorganisms are membrane-intercalated enzymes that catalyze the direct and stereospecific transfer of a hydride ion between the 4A position of NAD(H) and the 4B position of NADP(H). This transhydrogenation reaction is coupled to transmembrane proton translocation with a H+/H- stoichiometry of unity as shown in Equation 1 (1-3).
<UP>NADH</UP>+<UP>NADP</UP>+<UP>H</UP><SUP>+</SUP><SUB><UP>out</UP></SUB> ⇌ <UP>NAD</UP>+<UP>NADPH</UP>+<UP>H</UP><SUP>+</SUP><SUB><UP>in</UP></SUB> (Eq. 1)
The amino acid sequences of >30 TH are available, but only the enzymes from bovine mitochondria (4), Escherichia coli (5), and Rhodobacter capsulatus (6) have been purified. The bovine enzyme is a homodimer of monomer molecular mass of 109,065 Da. The monomer is composed of three domains: an amino-terminal 430-residue-long extramembranous domain I that binds NAD(H), a 400-residue-long central domain II that is composed of 14 transmembrane alpha  helices, and a carboxyl-terminal 200-residue-long extramembranous domain III that binds NADP(H) (1, 4, 7). The extramembranous domains I and III come together in the mitochondrial matrix to form the catalytic site of the enzyme. Bovine TH does not have a protein mass on the cytosolic side of the mitochondrial inner membrane with the exception of the oligopeptide loops, which connect appropriate transmembrane alpha  helices (8). The prokaryotic enzymes have the same general tridomain structure, but each monomer is made up of two (E. coli and R. capsulatus TH) or three (Rhodospirillum rubrum TH) subunits (1, 4, 5). In 1995, we discovered an interesting feature of the transhydrogenase (9). Because hydride ion transfer between NAD(H) bound to domain I and NADP(H) bound to domain III is direct, we reasoned that the respective nicotinamide moieties of these nucleotides must come within a few angstroms of each other for such direct hydride ion transfer to take place. If so, we further reasoned that the nucleotide binding regions of domains I and III must have complementary surfaces and attractive forces to allow the close approximation of the nicotinamide rings of their respective nucleotides. If these considerations were correct, then soluble domains I and III in the absence of the membrane-intercalated domain II might come together and catalyze transhydrogenation. This reasoning proved correct. We demonstrated that indeed isolated or recombinant transhydrogenase domains I and III from the same or different organisms did catalyze transhydrogenation when added to a reaction mixture in the absence of domain II (9) and that this transhydrogenation was especially efficient with recombinant R. rubrum domains I and III (10). The kinetics of transhydrogenation as catalyzed by recombinant domains I and III were subsequently further explored by others (11-13). The crystal structures of recombinant bovine (14) and human (15) domain III containing bound NADP, recombinant R. rubrum domain I containing bound NAD (16), and a recombinant R. rubrum domain I-III complex containing a domain I dimer with one mole of NAD bound to each monomer plus a domain III monomer with bound NADP (17) have been published. In addition, we have recently determined the crystal structure of recombinant R. rubrum domain I dimer in the absence and the presence of bound NADH.2

This paper concerns the proton channel of TH in the membrane-intercalated domain II of E. coli. Extensive site-directed mutagenesis studies have culminated in the identification of four amino acid residues, one each in domain II alpha  helices 9, 10, and 13 and one in the loop connecting alpha  helices 12 and 13, which appear to be required for coupled proton translocation by TH. On the basis of these and previous results, a mechanism for proton translocation coupled to transhydrogenation has been proposed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- NAD, NADH, NADPH, and ATP were obtained from Calbiochem. AcPyAD, AcPyADP, and 9-amino-6-chloro-2-methoxyacridine (ACMA) were obtained from Sigma. E. coli strain MC4100TH-, whose transhydrogenase gene was replaced with the kanamycin resistance gene, was reported previously (18).

Site-directed Mutagenesis-- The wild type transhydrogenase gene (pDC21) was digested with SalI/BamHI, and the resulting DNA fragment was inserted into the SalI/BamHI site of pTZ18U. With this plasmid derivative, site-directed mutagenesis was carried out using the reagents and protocols outlined in the Bio-Rad Muta-Gene mutagenesis kit (19). The plasmid DNA was prepared from individual colonies, and mutants were identified by DNA sequencing. The mutant DNA fragment was excised by appropriate restriction enzymes and replaced with the counterpart of pDC21.

Culture of E. coli Cells-- The E. coli strain MC4100TH- was transformed with pDC21 or mutant plasmids. Each single colony was inoculated into the LB medium containing ampicillin (100 µg/ml) and kanamycin (25 µg/ml). Cells were grown aerobically at 37 °C until the late logarithmic phase, collected by centrifugation at 8,000 rpm for 5 min (Sorvall GSA rotor), and washed with 0.9% NaC1.

Preparation of Membranes-- The cells (wet weight, ~ 0.65 g/liter LB medium) were suspended in 20 ml of 50 mM Tris-HCl (pH 7.8), containing 1 mM dithiothreitol and 5 mM MgC12 and sonicated in a Branson Sonifier at output 8 and 25% pulse for 5 min. Unbroken cells were removed by centrifugation at 15,000 rpm for 10 min in a Beckman model L ultracentrifuge, and membranes were collected by centrifugation at 40,000 rpm for 45 min. Membranes were suspended in 1.3 ml of the same buffer and homogenized.

Enzyme Assays-- Reverse transhydrogenase activity was assayed spectrophotometrically at 375 nm in a 37 °C reaction mixture (1 ml) containing 50 mM sodium phosphate (pH 7.0), 0.2 mM NADPH, 0.2 mM AcPyAD, and E. coli membranes (5-50 µg of protein). Cyclic transhydrogenase activity was measured at 375 nm in a 37 °C reaction mixture (1 ml) containing 50 mM MES-KOH (pH 6.0), 0.2 mM NADH, 0.2 mM AcPyAD, 10 µM NADPH, and E. coli membranes (5-50 µg of protein). ATP-dependent forward transhydrogenase activity was measured in a reaction mixture (1 ml) containing 50 mM Tris-H2SO4 (pH 7.8), 5 mM MgCl2, 2 mM dithiothreitol, 0.3 M KC1, 0.2 mM NADH, and 0.2 mM AcPyADP. This reaction was started by the addition of E. coli membranes (20-50 µg of protein), and 2-3 min later, 5 µl of 0.2 M ATP were added. The reduction of AcPyADP before and after ATP addition was monitored at 375 nm. An extinction coefficient of 6.1 mM-1 cm-1 was used to calculate the rates.

Proton Translocation-- Proton translocation coupled to reverse transhydrogenation catalyzed by E. coli membranes was monitored by measuring the quenching of ACMA fluorescence. The reaction mixture (2 ml) contained 10 mM HEPES-KOH (pH 7.4), 5 mM MgCl2, 0.3 M KCl, 2 µM ACMA, 0.2 mM NADPH, 0.4 mM AcPyAD, and E. coli membranes (10-100 µg of protein). ACMA fluorescence was measured at 37 °C by a SLM photon-counting fluorescence spectrophotometer using an excitation wavelength of 415 nm and an emission wavelength of 485 nm. The reaction was started by the addition of AcPyAD. Proton translocation coupled to ATP hydrolysis or NADH oxidation was measured similarly in the above reaction mixture with the exception that NADPH and AcPyAD were not included and the reaction was started by the addition of 200 µM ATP or 50 µM NADH.

Protein Determination.-- Protein concentration was determined using the BCA protein assay reagents (Pierce).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Meuller and Rydström (20) have shown that the membrane-intercalated domain II of the two-subunit E. coli TH monomer is composed of 13 transmembrane alpha  helices, 4 helices at the COOH terminus of the alpha  subunit and 9 helices at the NH2 terminus of the beta  subunit. The domain II of the single subunit bovine TH monomer is composed of 14 continuous transmembrane alpha  helices (1, 4). Meuller and Rydström (20) showed that the E. coli TH lacks the segment corresponding to the fifth bovine alpha  helix and recommended that for easy interspecies comparison, the transmembrane alpha  helices of E. coli TH be designated as shown in Fig. 1 (i.e. the alpha  subunit ending with helix 4 and the beta  subunit starting with helix 6).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Domain II of E. coli TH. The essential residues beta His-91, beta Ser-139, beta Asp-213, and beta Asn-222 are highlighted in black circles. beta Glu-85 is in a black square, and the conserved glycine residues of helices 9, 10, 13, and 14 are shown in bold. For details, see "Results." This figure was adapted from that in Ref. 20.

For reasons that are detailed under "Discussion" (also for review see Ref. 1), we considered that the proton channel of TH is probably located in the segment of the beta  subunit between transmembrane alpha  helices 9 and 14. Therefore, a systematic mutational study was undertaken in which the effects of mutations of prototropic residues were investigated, mainly in this segment of domain II of the E. coli TH. The mutant E. coli membranes were assayed for the following activities: reverse transhydrogenation from NADPH to the NAD analogue AcPyAD; cyclic transhydrogenation in the presence of NADPH from NADH to AcPyAD (10, 21, 22); proton translocation coupled to reverse transhydrogenation; and proton translocation coupled to ATP hydrolysis and/or NADH oxidation. The latter assays were considered important controls, because they checked membrane integrity where TH mutations appeared to have inhibited transhydrogenation-coupled proton translocation. The results obtained have been separated into two tables. Table I shows the results of the mutations of 21 conserved and semiconserved (with the exception of beta Lys-149) prototropic residues, which appeared to be nonessential. As seen in this table, certain mutations had large effects on one or more of the activities tested. In the absence of information regarding the overall structure of the TH molecule, it is difficult to rationalize the effects of these mutations on the TH activities shown in Table I. However, certain possibilities can be conceived regarding the results of mutations of beta Glu-85, which are considered under "Discussion."

                              
View this table:
[in this window]
[in a new window]
 
Table I
Catalytic properties of E. coli TH mutated at 21 prototropic amino acid residues of the beta  subunit domain II
All of the values given here and in Table II were calculated as the percent of the wild type activities, which were as follows: reverse TH activity, 1.66, µmol of AcPyAD reduced by NADPH (min · mg of protein)-1; cyclic TH activity, 8.7 µmol of AcPyAD reduced by NADH (min · mg of protein)-1; proton translocation, the initial rate in arbitrary units of ACMA fluorescence quenching per milligram of wild type membranes (see "Experimental Procedures"). All calculated values were rounded to the nearest integer. In this Table, >= 100 covers the range 101-120%, and >100 means >120%. Here and in Table II where mutations resulted in considerable activity loss, the results were confirmed in independent experiments. The data shown are averages of duplicate or triplicate experiments.

Table II shows the results of mutations of four other prototropic residues of the beta  subunit of TH domain II. As was shown previously by others and confirmed here, beta His-91 (23) and beta Asn-222 (24) appeared to be essential residues. One reason for repeating and extending the mutational studies of others was that they had not stated whether their E. coli membrane preparations containing the TH mutants incapable of transhydrogenation coupled proton translocation were otherwise intact and capable of forming a proton electrochemical potential coupled to ATP hydrolysis and/or respiration. Although not shown in Tables I and II, we carried out this important membrane integrity test in all of the cases where proton translocation rates and extents coupled to reverse transhydrogenation were nil or drastically diminished. The results showed that all the E. coli membrane preparations containing TH mutants with impaired proton translocation activity were capable of rapid proton translocation coupled to ATP hydrolysis and NADH oxidation. Another reason was that certain literature reports showed substantial proton translocation activity for mutants that exhibited negligible reverse TH activity (see below).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Catalytic properties of E. coli TH mutated at amino acid residues beta His-91, beta Ser-139, beta Asp-213, and beta Asn-222

As seen in Table II, the mutation of beta His-91 appeared to be tolerated to various low extents for reverse and cyclic transhydrogenation but not for proton translocation. Among the beta His-91 mutations, the replacement of this residue with Asn did not alter the reverse TH activity but greatly diminished cyclic and proton translocation activities. Literature data on the activities of beta H91N mutation are mixed. The reverse TH activity reported for this mutation ranges from 80 (25-27) to 18% (28) relative to the wild type activity. However, these reports agree that beta H91N mutation greatly inhibits proton translocation. It has been reported that beta H91K and beta H91R mutants exhibit relative to the wild type, respectively, 2 and 1% reverse TH activity, and 30 and 25% proton pumping activity (28). As seen in Table II, our beta H91K and beta H91R mutants were not only impaired for reverse transhydrogenation, they were also incapable of proton translocation. In the TH of certain microorganisms (e.g. Mycobacteria), the residue corresponding to beta His-91 is Asn. In these organisms, the amino acid residues following Asn are also different. In E. coli, the sequence starting at beta His-91 is HSFVGLA, whereas in Mycobacterium leprae and Mycobacterium tuberculosis, the sequence is NGVGGGT. Whether the TH in these organisms is incapable of proton translocation or more probably the nearby residue changes make it possible for Asn to perform the same function as beta His-91 of E. coli TH remains to be seen (see also Ref. 29). However, it should be mentioned that in these organisms the residues corresponding to the other three essential residues shown in Table II are all conserved. As seen in Tables I and II, cyclic TH activity is generally close to reverse TH activity with the exception of the case of beta H91K mutation (Table II) where reverse TH activity is greatly diminished but cyclic activity is very high. This may be related to the finding of Bragg and Hou (28) that beta H91K mutants contain bound NADP(H), which would favor the cyclic reaction (1, 10, 21, 22).

Another domain II residue previously shown to affect TH catalytic and proton translocation activities when mutated is beta Asn-222 (24). Our extensive mutational data in support of the essential role of beta Asn-222 are shown in Table. II. It is seen that in contrast to all of the other beta Asn-222 mutations, which completely inhibited proton translocation, beta N222C and beta N222D exhibited a low level of proton translocation activity (see also Ref. 24). This observation is not inconsistent with our proposed mechanism of proton translocation by TH (see "Discussion").

We had shown earlier that beta Asp-213, the only conserved dicarboxylic acid residue in the entire domain II of TH, appears to play a role in proton translocation (18). Its mutation to Asn and Ile resulted in parallel losses, respectively, of 70 and 90% reverse transhydrogenation and proton translocation activities. The results of additional mutations of this residue shown in Table II support our previous findings. It is seen that the mutation of beta Asp-213 to Glu was partially tolerated, but other mutations greatly inhibited catalytic activity and nearly completely abolished proton translocation activity. Our results regarding the mutation of beta Asp-213 to Lys and Arg differ from those of others. Bragg and Hou (28) have reported that as compared with wild type, beta D213K exhibited 7% reverse and 49% proton translocation activities and beta D213R showed 5% reverse and 28% proton translocation activities. Bragg and Hou (28) do not explain how it is possible for the rate of the exergonic reverse transhydrogenation to be so much lower than the rate of the coupled endergonic proton translocation (see also above for data on beta H91K and beta H91R mutants). We appreciate that the different monitoring methods used (absorbance versus fluorescence) can result in small differences between the estimated rates of hydride ion transfer and proton translocation, especially when the results are calculated as percent of wild type activities. However, in our hands, beta H91K and beta H91R were incapable of proton translocation (see above and Table II), and beta D213K and beta D213R exhibited marginal rates of proton translocation commensurate with their very low reverse transhydrogenation activities.

The finding that beta Ser-139 appears to be essential is new and agrees with our previous suggestion regarding the possible role of conserved hydroxylated residues, which are prevalent in the distal helices of domain II (1). The situation with beta Ser-139 is particularly interesting. As seen in Table II, this residue could not tolerate the mutation to Ala, Asp, His, Lys, Leu, or Asn. In all of these cases, proton translocation was completely abolished. However, the replacement of the hydroxymethyl group of beta Ser-139 with the hydroxyethyl of threonine or the thiomethyl of cysteine was tolerated. These results as well as the permissible beta S139G mutation are understandable in terms of our concept regarding the mechanism of proton translocation by TH, which is described under "Discussion."

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Proton Channel of TH-- The reason for concentrating our domain II mutagenesis studies on the segment of this domain downstream of helix 8 was that this region contains a highly conserved sequence of amino acids, especially around beta His-91 in helix 9, around beta Ser-139 in helix 10, in the extramembranous loop connecting helices 12 and 13, and throughout the remainder of domain II and approximately 15 residues in the extramembranous region beyond helix 14. This high degree of sequence conservation is rare among the hydrophobic domains of other proteins and was therefore suggestive of functional significance. The data reported in Tables I and II show that among 25 conserved and semiconserved prototropic residues of domain II of the E. coli TH, which were mostly located in helices 9-14, four residues, namely, beta His-91, beta Ser-139, beta Asp-213, and beta Asn-222, appear to be essential for proton translocation. beta Asp-213 is considered to be located outside the membrane in a cytosolic-side loop that connects transmembrane helices 12 and 13, whereas beta His-91, beta Ser-139, and beta Asn-222 are located, respectively, in helices 9, 10, and 13 (Fig. 1). We propose that in the native structure of TH, alpha  helices 9, 10, and 13 come together possibly with the highly conserved helix 14 to form a four-helix bundle in which residues beta His-91, beta Ser-139, and beta Asn-222 participate together with bound water molecules in a hydrogen-bonded network for proton conductance (see also Ref. 29). The participation of bound water in proton conductance has been demonstrated in bacteriorhodopsin (30-32) and appears very likely in cytochrome c oxidase (33-35). In Fig. 1, beta His-91, beta Ser-139, and beta Asn-222 are shown at approximately the same depth from either side of alpha  helices 9, 10, and 13. However, it should be pointed out that the correct structure of domain II is not known, and it is possible that these essential residues are located in such positions in their respective alpha  helices that together with bound water they span the membrane from the cytosolic to the periplasmic side. Furthermore, it may be noted that dispersed throughout the proposed four-helix bundle are eight conserved glycines in the 33 available TH sequences. In the E. coli TH (see Fig. 1) these conserved glycines are beta Gly-95 in helix 9, beta Gly-132 (Ala in Eimeria tenella) and beta Gly-138 in helix 10, beta Gly-226 and beta Gly-233 in helix 13, and beta Gly-245, beta Gly-249 (Ala in E. tenella), and beta Gly-252 in helix 14. Together these conserved glycines may be required for the formation of a channel for bound water within the proposed four-helix bundle.

A proton channel as proposed here would agree with the mutational data reported in Table II. Thus, the permissible mutations beta S139T and beta S139C are understandable, because the hydroxyethyl group of threonine and the thiomethyl group of cysteine could easily be considered to perform the same role as the hydroxymethyl of serine in the hydrogen bond network described above. The low proton translocation activities of beta N222D and beta N222C could also be rationalized in terms of the ability of Asp and Cys to participate via hydrogen bonding in proton conductance. Furthermore, the permissible beta S139G mutation is not as surprising as it seems. One can conceive of the vacancy created by the absence of the hydroxymethyl of serine to be filled with a molecule of water and its participation in proton conductance through the hydrogen bond network. As seen in Table I, the mutations of beta Glu-85 resulted in variable low activities. It is difficult to consider beta Glu-85 as an essential residue, because in the TH of many organisms, beta Glu-85 is replaced with Gln and because all of the beta Glu-85 mutations shown in Table I were tolerated to variable small extents. However, the location of beta Glu-85 is of interest (a) because of its proximity to beta His-91 in the alpha  helical structure of helix 9, and (b) because in the proposed helix bundle, beta Glu-85 may come close to beta Asp-213 and assist in efficient proton conductance from beta Asp-213 into the proton channel (see below). We have checked the possibility that in the E. coli TH beta Glu-85 may take part together with beta Asp-213 in proton conductance between domains II and III by mutating both residues to Ala. The resulting beta E85A/beta D213A double mutant showed only 1% reverse TH activity as compared with wild type and was completely incapable of proton translocation.

The TH Energy Coupling Mechanism-- As seen in Equation 1, reverse transhydrogenation from NADPH to NAD is coupled to outward proton translocation. Because the difference in the reduction potentials of NADPH/NADP and NADH/NAD couples is negligible (Delta E<UP><SUB><IT>0</IT></SUB><SUP><IT>′</IT></SUP></UP> ~ 5 mV) and all of the substrates and products are located on the same side of the membrane, the driving force for outward proton translocation in the above reaction would have to be the difference in the chemical potentials of substrates and products, which in an enzymatic reaction means the difference in the binding energies of reactants and products. It further means that the enzyme would have to utilize this binding energy for outward proton translocation by undergoing a substrate-promoted conformation change. In forward transhydrogenation, the protonmotive force would then be expected to alter enzyme conformation and substrate/product affinities, resulting in facilitation of the forward reaction (1, 4).

Our early studies provided support for the above expectations. We first obtained evidence in submitochondrial particles that TH utilizes the proton motive force for cyclic conformation change in forward transhydrogenation (1, 36) and demonstrated a proton motive force-promoted substrate affinity increase of ~9-10 kJ/mol during hydride ion transfer from NADH to the NADP analogue AcPyADP (1, 4, 37, 38). Finally, using purified bovine TH, we showed for the first time that the binding of NADPH but not of NADH, NAD, or NADP, made two distant peptide bonds (Lys410-Thr411 at the junction of domains I and II and Arg602-Leu603 in the domain II extramembranous loop connecting alpha  helices 6 and 7) susceptible to trypsin hydrolysis (4, 39). These results indicated that NADPH binding at domain III alters the conformation of this domain and its position relative to domains I and II. This finding was subsequently supported by data for the E. coli enzyme (40).

We have now shown that the conserved beta Asp-213 of E. coli TH, which is probably located in the domain II extramembranous loop connecting alpha  helices 12 and 13, is necessary for efficient proton translocation coupled to reverse transhydrogenation (Table II). This finding provides for a mechanism whereby the NADPH-promoted conformation change of domain III can be linked to the proton channel of the enzyme in domain II (see above). It has been suggested by others that the conserved beta Asp-392 at the NADPH binding site may be involved in proton translocation (41). One can certainly conceive of the possibility that the NADPH-promoted conformation change of domain III makes it possible for beta Asp-392 to release a proton, which would somehow be conveyed to the domain II proton channel via beta Asp-213 (Fig. 2). As mentioned above, the NADPH-promoted conformation change of domain III appears to move this domain away from the top of domain II as suggested by our previous work showing that Arg602-Leu603 bond in the loop between helices 6 and 7 becomes susceptible to trypsin attack (39). This movement of domain III away from domain II could make the environment of beta Asp-213 more hydrophilic and lower its pKa, resulting in proton release into the nearby proton channel. Using the catalytically active cysteine-free mutant of E. coli TH as the parent enzyme, Althage et al. (42) have converted beta Asp-213 and beta Arg-265 separately and together to Cys in this otherwise cysteine-free protein. They have shown that both beta D213C and beta R265C mutants react with a fluorescent maleimide and that the presence of NADP(H) considerably increases the accessibility of the Cys residues to the maleimide derivative. beta Arg-265 is located five residues beyond helix 14 at the junction between domains II and III. When the fluorescent maleimide was added to the double mutant beta D213C/beta R265C, it reacted poorly, suggesting to the authors that the two Cys residues have formed a disulfide bond. The authors infer from these data that in the native TH beta Asp-213 and beta Arg-265, which they consider is not an essential residue, form a salt bridge. If so, this interaction would interfere with our proposed role of beta Asp-213 in proton conductance. However, Althage et al. (42) state that their double mutant TH contained no bound nucleotides and have shown as recounted above that the presence of NADP(H) greatly increases the accessibility of beta D213C and beta R265C to modification by the fluorescent maleimide. Therefore, it seems probable that in the functioning enzyme substrate-promoted conformation changes, which increase the solvent exposure of these residues, would also prevent their coming together to form a salt bridge and allow beta Asp-213 to function in proton conductance. Returning to the proposed mechanism, we would expect that in forward transhydrogenation, incoming protons would follow the path described above (i.e. through the hydrogen-bonded channel of domain II to beta Asp-213 and domain III), resulting in affinity increase for NADP, which we have earlier shown (1, 4, 37, 38), and probably in affinity decrease for NADPH as suggested by kinetic data.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 2.   The proposed four-helix bundle proton channel of E. coli TH in domain II. The proton channel is composed of alpha  helix 9 containing the essential residue beta His-91, helix 10 containing the essential residue beta Ser-139, helix 13 containing the essential residue beta Asn-222, and helix 14 containing 16 conserved residues. The essential residue beta Asp-213 is proposed to be located near the channel on the cytosolic side, and beta Glu-85 in helix 9 may assist in the E. coli enzyme in proton conductance between the channel and beta Asp-213 (for details, see "Discussion"). Domain III appears to be located close to the cytosolic side of domain II. The structure of NADP(H) as adapted from Ref. 14 and beta Asp-392 as suggested by others (41) to be involved in proton translocation are also shown. However, no information is available for the path of protons, if any, between beta Asp-392 and domain II. The relative sizes of alpha  helices and NADP(H) and the distances shown among the alpha  helices and between beta Asp-213 and beta Asp-392 are arbitrary.


    ACKNOWLEDGEMENTS

We thank Maria Latev and Cristel Cortinas-Miller for expert technical assistance.

    FOOTNOTES

* This work was supported by the National Institutes of Health, United States Public Health Service Grants GM61545 and DK08126 (to Y. H.). Synthesis of nucleotides was supported in part by the Sam and Rose Stein Endowment Fund. This is publication number 14628-MEM from The Scripps Research Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 858-784-8092; Fax: 858-784-2054; E-mail: hatefi@scripps.edu.

Published, JBC Papers in Press, June 26, 2002, DOI 10.1074/jbc.M204170200

2 G. S. Prasad, M. Wahlberg, V. Sridhar, Y. Sundaresan, M. Yamaguchi, Y. Hatefi, and C. D. Stout, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: TH, transhydrogenase; AcPyAD, 3-acetylpyridine adenine dinucleotide; AcPyADP, 3-acetypyridine adenine dinucleotide phosphate; ACMA, 9-amino-6-chloro-2-methoxyacridine; MES, 2-(N-morpholino)ethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hatefi, Y., and Yamaguchi, M. (1996) FASEB J. 10, 444-452[Abstract]
2. Jackson, J. B., Peake, S. J., and White, S. A. (1999) FEBS Lett. 464, 1-8[CrossRef]
3. Bizouarn, T., Fjellström, O., Meuller, J., Axelsson, M., Bergkvist, A., Johansson, C., Karlsson, B. G., and Rydström, J. (2000) Biochim. Biophys. Acta 1457, 211-228[Medline] [Order article via Infotrieve]
4. Hatefi, Y., and Yamaguchi, M. (1992) in Molecular Mechanisms in Bioenergetics (Ernster, L., ed) , pp. 265-281, Elsevier Science Publishers B.V., Amsterdam
5. Clarke, D. M., and Bragg, P. D. (1985) Eur. J. Biochem. 149, 517-523[Medline] [Order article via Infotrieve]
6. Lever, T. M., Palmer, T., Cunningham, I. J., Cotton, N. P. J., and Jackson, J. B. (1991) Eur. J. Biochem. 197, 247-255[Medline] [Order article via Infotrieve]
7. Yamaguchi, M., and Hatefi, Y. (1993) J. Biol. Chem. 268, 17871-17877[Abstract/Free Full Text]
8. Yamaguchi, M., and Hatefi, Y. (1991) J. Biol. Chem. 266, 5728-5735[Abstract/Free Full Text]
9. Yamaguchi, M., and Hatefi, Y. (1995) J. Biol. Chem. 270, 28165-28168[Abstract/Free Full Text]
10. Yamaguchi, M., and Hatefi, Y. (1997) Biochim. Biophys. Acta 1318, 225-234[Medline] [Order article via Infotrieve]
11. Venning, J. D., Grimley, R. L., Bizouarn, T., Cotton, N. P. J., and Jackson, J. B. (1997) J. Biol. Chem. 272, 27535-27538[Abstract/Free Full Text]
12. Venning, J. D., Bizouarn, T., Cotton, N. P. J., Quirk, P. G., and Jackson, J. B. (1998) Eur. J. Biochem. 257, 202-209[Medline] [Order article via Infotrieve]
13. Pinheiro, T. J. T., Venning, J. D., and Jackson, J. B. (2001) J. Biol. Chem. 276, 44757-44761[Abstract/Free Full Text]
14. Prasad, G. S., Sridhar, V., Yamaguchi, M., Hatefi, Y., and Stout, C. D. (1999) Nat. Struct. Biol. 6, 1126-1131[CrossRef][Medline] [Order article via Infotrieve]
15. White, S. A., Peake, S. J., McSweeney, S., Leonard, G., Cotton, N. P. J., and Jackson, J. B. (2000) Structure 8, 1-12[Medline] [Order article via Infotrieve]
16. Buckley, P. A., Jackson, J. B., Schneider, T., White, S. A., Rice, D. W., and Baker, P. J. (2000) Structure 8, 809-815[Medline] [Order article via Infotrieve]
17. Cotton, N. P. J., White, S. A., Peake, S. J., McSweeney, S., and Jackson, J. B. (2001) Structure 9, 165-176[Medline] [Order article via Infotrieve]
18. Yamaguchi, M., and Hatefi, Y. (1995) J. Biol. Chem. 270, 16653-16659[Abstract/Free Full Text]
19. Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382[Medline] [Order article via Infotrieve]
20. Meuller, J., and Rydström, J. (1999) J. Biol. Chem. 274, 19072-19080[Abstract/Free Full Text]
21. Fisher, R. R., and Earl, S. R. (1982) in The Pyridine Nucleotide Coenzymes (Everse, J. , Anderson, B. , and You, K.-S., eds) , pp. 279-324, Academic Press, Orlando, FL
22. Hutton, M., Day, J. M., Bizouarn, T., and Jackson, J. B. (1994) Eur. J. Biochem. 219, 1041-1051[Medline] [Order article via Infotrieve]
23. Olausson, T., Fjellström, O., Meuller, J., and Rydström, J. (1995) Biochim. Biophys. Acta 1231, 1-19[Medline] [Order article via Infotrieve]
24. Bragg, P. D., and Hou, C. (1999) Arch. Biochem. Biophys. 363, 182-190[CrossRef][Medline] [Order article via Infotrieve]
25. Glavas, N. A., Hou, C., and Bragg, P. D. (1995) Biochemistry 34, 7694-7702[CrossRef][Medline] [Order article via Infotrieve]
26. Bragg, P. D., and Hou, C. (1996) Eur. J. Biochem. 241, 611-618[Medline] [Order article via Infotrieve]
27. Bragg, P. D. (1998) Biochim. Biophys. Acta 1365, 98-104[Medline] [Order article via Infotrieve]
28. Bragg, P. D., and Hou, C. (2001) Arch. Biochem. Biophys. 388, 299-307[CrossRef][Medline] [Order article via Infotrieve]
29. Bizouarn, T., Meuller, J., Axelsson, M., and Rydström, J. (2000) Biochim. Biophys. Acta 1459, 284-290[Medline] [Order article via Infotrieve]
30. Lanyi, J. K. (1998) J. Struct. Biol. 124, 164-178[CrossRef][Medline] [Order article via Infotrieve]
31. Lanyi, J. K. (1999) Int. Rev. Cytol. 187, 161-202[Medline] [Order article via Infotrieve]
32. Maeda, A., Balashov, S. P., Luglenburg, J., Verhoeven, M. A., Herzfeld, J., Belenkg, M., Gennis, R. B., Tomson, F. L., and Ebrey, T. G. (2002) Biochemistry 41, 3803-3809[CrossRef][Medline] [Order article via Infotrieve]
33. Wikström, M., Morgan, J. E., and Verkhovsky, M. I. (1998) J. Bioenerg. Biomembr. 30, 139-145[CrossRef][Medline] [Order article via Infotrieve]
34. Zaslavsky, D., and Gennis, R. B. (2000) Biochim. Biophys. Acta 1458, 164-179[Medline] [Order article via Infotrieve]
35. Wikström, M. (2000) Biochim. Biophys. Acta 1458, 188-198[Medline] [Order article via Infotrieve]
36. Hatefi, Y., Phelps, D. C., and Galante, Y. M. (1980) J. Biol. Chem. 255, 9526-9529[Abstract/Free Full Text]
37. Galante, Y. M., Lee, Y., and Hatefi, Y. (1980) J. Biol. Chem. 255, 9641-9646[Abstract/Free Full Text]
38. Hatefi, Y., Yagi, T., Phelps, D. C., Wong, S.-Y., Vik, S. B., and Galante, Y. M. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 1756-1760[Abstract/Free Full Text]
39. Yamaguchi, M., Wakabayashi, S., and Hatefi, Y. (1990) Biochemistry 29, 4136-4143[CrossRef][Medline] [Order article via Infotrieve]
40. Tong, R. C. W., Glavas, N. A., and Bragg, P. D. (1991) Biochim. Biophys. Acta 1080, 19-28[CrossRef][Medline] [Order article via Infotrieve]
41. Hu, X., Zhang, J., Fjellström, O., Bizouarn, T., and Rydström, J. (1999) Biochemistry 38, 1652-1658[CrossRef][Medline] [Order article via Infotrieve]
42. Althage, M., Bizouarn, T., and Rydström, J. (2001) Biochemistry 40, 9968-9976[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Yamaguchi and C. D. Stout
Essential Glycine in the Proton Channel of Escherichia coli Transhydrogenase
J. Biol. Chem., November 14, 2003; 278(46): 45333 - 45339.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/37/33670    most recent
M204170200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Hatefi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, M.
Right arrow Articles by Hatefi, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals